Lateral Epicondylitis (Tennis Elbow) Market by Treatment type (Corticosteroid Injections, Surgery, Therapy (Shock Wave Therapy & Physical Therapy), Painkillers and NSAIDS, Equipment's and Other Products, By End User (Hospital/Clinic and Pharmacy/Drug Stores), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2016-26

Published:
May 2020
Report Code:
BWC20065
Available Format:
PDF PDF Icon
Pages:
179

lateral epicondylitis (tennis elbow) market bwc20065

COVID-19

We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at

Contact Now

Market Share & Forecast, 2016-26

Global Lateral Epicondylitis (Tennis Elbow) Market Size- Industry Trends & Forecast Report 2026

The global market of Lateral Epicondylitis (Tennis Elbow) witness market size of USD 8,953.51 Million in 2019 and projected to reach market size of 1,0397.04 at a CAGR of 2.32% during the forecast period of 2020-2026. The growing burden of lateral epicondylitis, increase in target population, and launch of cost-effective treatment options are the major growth propellers for the market.

In addition, increasing efforts undertaken by major companies for the development of technological advanced products will also support market growth. Involvement of international organizations serves as a catalyst in tennis elbow treatment market. In addition, new product introduction enabling effective treatment for lateral epicondylitis (tennis elbow) will fuel the growth of lateral epicondylitis (tennis elbow) market. Some of the drugs under trial include hyaluronate sodium, botulinum toxin and topical nitrates. The promotion of physical exercise is an essential strategy of health promotion. Since sports participation entails the risk of injuries that account for substantial morbidity and disability, the existence of adequate epidemiological information is essential for the development of sound preventive strategies. There are number of other activities responsible for tennis elbow depends upon age group and activity type.

Global Lateral Epicondylitis (Tennis Elbow) Market: Overview

A common musculoskeletal condition causing pain and functional weakness is lateral epicondylitis, or tennis elbow. Caused by repeated arms and elbow movements. A kind of tendinitis, the disease includes tendon swelling and is diagnosed on medical checkup. Lateral epicondylitis (tennis elbow) is an inflammatory syndrome usually found in tennis players, baseball players, swimmers, carpenters, plumbers and anyone who over and over performs an arm movement.

Pain is localized around the lateral elbow and dorsal forearm regions. The condition aggravates on extending wrist against the resistance. Lateral epicondylitis (tennis elbow) can be diagnosed through medical imaging test such as X-ray, MRI or electromyography (EMG). Men and women of age group 35 years to 60 years are afflicted with this condition predominantly. Although different nonsurgical conservative therapies such as bracing, physical therapy, nonsteroidal anti-inflammatory drugs, and corticosteroid injections in addition to surgical approaches have been used, yet there is no standard treatment for lateral epicondylitis.

Growth Drivers

Increasing Cases of Lateral Epicondylitis and Sport-Related Injuries

Age and improper equipment used by athletes are some of the major factors responsible for lateral epicondylitis (tennis elbow). Moreover, people participating in recreational activities are bound to do repetitive actions involving the frequent movement of elbow. Risk for lateral epicondylitis (tennis elbow) is high in this population. In younger people, a piece of cartilage or bone in the joints may loosen due to osteochondritis dissecans leading to lateral epicondylitis. As this condition is not limited to athletes alone, the demand for available and anticipated treatment has increased substantially in recent years, in turn, driving the expansion of the global lateral epicondylitis treatment market.

Ø  As per the Stanford Children’s Health, each year around 3.5 million children ages 14 and below are affected by some form of sport-related injuries. The aforementioned factors are likely to drive the demand for tennis elbow treatment. Ennis elbow is the most common cause of elbow symptoms in patients presenting with elbow pain in general. 

Ø  The condition tends to affect men and women equally. Half of tennis players develop pain around the elbow, of which 75% represent true tennis elbow. It is more common in individuals older than 40 years of age.

Technological Advancement and favorable Reimbursement

Rising favorable reimbursement from government authority and technological advancement in the treatment sector becoming a key booster to drive growth trend of lateral epicondylitis market. Agencies, such as the Centers for Medicare and Medicaid offer up to 80% reimbursement for knee braces. The aforementioned factors are driving the demand for the product. New product introduction enabling effective treatment for lateral epicondylitis (tennis elbow) will fuel the growth of lateral epicondylitis (tennis elbow) market in upcoming years. Some of the drugs under trial include hyaluronate sodium, botulinum toxin and topical nitrates. TENEX procedure is one of the promising procedure, where a needle is inserted into the injured tendon and ultrasonic energy is used to vibrate the needle to break up the damaged tissue so that it can be removed.

Restraint

Sluggish Adoption Trend of New Effective Therapies

Sluggish adoption trend of new effective therapies is expected to pose hurdle for the growth of this market over coming few years. The devices are expensive when compared to few of the alternate methods. Payers, regulators and customers are demanding better clinical and economic outcomes, while legacy product lines are becoming commoditized and price erosion is impacting all treatment segments of the lateral epicondylitis market. Improper diagnosis to differentiate the requirement of accurate treatment type also impacting market in terms of value in current and upcoming years.

Global Lateral Epicondylitis (Tennis Elbow) Market: Treatment Type

Based on treatment type the global lateral epicondylitis market segmented into corticosteroid injection, surgery, therapy, painkillers and NSAIDS and Equipment's and Other Products. Surgery segment includes treatment such as arthroscopy, open surgeries etc. that are opted as a final remedial measure for treating tennis elbow. Technological advancements in the nature of surgical equipment and guidance systems will support the demand for these treatment methods. Furthermore, growing preference for minimally invasive procedures due to advantages such as quicker recuperation, better safety outcomes, less blood loss and low risk of infection are the major factors that urge the demand for arthroscopy for tennis elbow treatment.

Global Lateral Epicondylitis (Tennis Elbow) Market: End User

The global market is segregated into Hospital/Clinic and Pharmacy/Drug Stores. Tie-ups of government authorities with hospital for player’s safety and insurance driving growth of hospital segment. The U.S. Department of Health and Human Services’ National Youth Sports Strategy for increasing awareness of the benefits of participation in sports and regular physical activity, as well as the importance of good nutrition is boosting the regional growth for the market. Furthermore, favorable reimbursement scenario bodes a well for brace segment. Agencies, such as the Centers for Medicare and Medicaid offer up to 80% reimbursement for knee braces. The aforementioned factors are driving the demand for the product.


Global Lateral Epicondylitis (Tennis Elbow) Market: Regional Insights

On the geographical region basis, the global lateral epicondylitis market segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Amidst the segmentation due to rising disposable income, well establishes healthcare infrastructure and presence of leading players headquarter in the North America region. Asia-Pacific projected to grow with significant growth rate in upcoming years with the increasing trend of government initiatives and medical tourism in the region due to low cost structure in comparison with developed region. Depending upon the patient condition treatment type varies spray, therapy, and injection contributing with high market share across the region while surgery is dominating the regional market. The side effects associated with corticosteroid injections, painkillers and NSAIDS with temporary relief property projected to impede market growth in upcoming years with significant rate in the MEA region.


Competitive Landscape

The global tennis elbow treatment market is consolidated in nature. Various companies are striving to gain market share by adopting competitive strategies such as joint ventures and research partnerships. Some key players operating in the market include Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex and other prominent players. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development. For instance, Zimmer Biomet's, Tether treatment of scoliosis, providing a fusion-less alternative for young patients requiring surgery for young patients with scoliosis receives FDA approval.

Recent Development

Ø  November 2019, Prolotherapy injections and physiotherapy used singly and in combination for lateral epicondylalgia: a single-blinded randomised clinical trial.

Ø  March 2019, New IR treatment for 'tennis elbow' reduces pain and inflammation without surgery

Ø  Sep 2018, Platelet-Rich Plasma (PRP) is currently being investigated for its effectiveness in speeding the healing of a variety of tendon injuries

The objective of the Study:

Ø  To analyze and forecast the global Lateral Epicondylitis (Tennis Elbow) market size of the market in terms of value.

Ø  To examine the careful market segmentation and forecast the market size, in terms of value, based on the region by segmenting.

Ø  The Global Lateral Epicondylitis (Tennis Elbow) market segmented into five regions, namely, North America, Europe, Asia Pacific, Middle East, South America, and their leading countries.

Ø  To outline, categorized, and forecast the global Lateral Epicondylitis (Tennis Elbow) market based on the treatment type and end user coupled with the region.

Ø  To examine competitive developments like technological advancement, services, and regulative framework within the global Lateral Epicondylitis (Tennis Elbow) market.

Ø  To highlight the impact analysis of the factors affecting the market dynamics such as drivers, restraints, opportunities, and challenges.

Ø  To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

Scope of the Report

·         By Treatment Type

Ø  Corticosteroid Injections

Ø  Surgery

Ø  Therapy (Shock Wave Therapy & Physical Therapy)

Ø  Painkillers and NSAIDS

Ø  Equipment's and Other Products

·         By End User

Ø  Hospital/Clinic

Ø  Pharmacy/Drug Stores

·         By Region:  

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa

 

Attribute

Details

Years Considered

Historical data – 2016-2019

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Million/Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia

Product/Service Segmentation

By Treatment Type and End-User

Key Players

Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex  and other prominent players.

 



WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.